Monurol Comparator Drug Efficacy Must Be Revealed In Ads, FDA Tells Forest
Executive Summary
Efficacy of comparator drugs must be revealed in promotional pieces, FDA's Division of Drug Advertising and Communications told Forest Labs in a April 27 notice of violation letter regarding promotions for the bladder infection treatment Monurol (fosfomycin tromethamine).